Form 483

Corium Innovations, Inc. Form 483, 2009-03-26

FDA issued a Form 483 to Corium Innovations, Inc. on 2009-03-26 with 9 public-safe observations.

483· Form 483 issued9 observations

Corium Innovations, Inc. · Grand Rapids, United States · Issued March 26, 2009

Overview

  • 9 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Mar 2009
21 CFR 211.84(e)

Rejecting When Specifications Not Met

Cited by Martha Sullivan Myrick, Adam J Wilson

26 Mar 2009
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Martha Sullivan Myrick, Adam J Wilson

26 Mar 2009
21 CFR 211.110(b)

In-process materials specifications

Cited by Martha Sullivan Myrick, Adam J Wilson

26 Mar 2009
21 CFR 211.186(b)(9)

Manufacturing Instructions and Specifications

Cited by Martha Sullivan Myrick, Adam J Wilson

26 Mar 2009
21 CFR 211.188

Prepared for each batch, include complete information

Cited by Martha Sullivan Myrick, Adam J Wilson

Inspected site

CICorium Innovations, Inc.Grand Rapids, United States

Inspection team

MSMartha Sullivan Myrick

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.194(a)(2)Cited across public-safe Form 483 observations2x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.110(b)Cited across public-safe Form 483 observations1x
21 CFR 211.186(b)(9)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.84(e)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere